F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
Last updated: 2026-07-26 21:23:02 ET
The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.
The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide dr...
The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should ...
Outside experts—some with a vested interest in peptides—recommended adding a number of the amino acids to the FDA's bulk list, including the “Wo...
The vote marks a win for Health Secretary Robert F Kennedy who has said he's a big fan of the drugs, which haven't been well studied for human use.
Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK JrA panel of federal health advisers ...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE